Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P. - Net Worth and Insider Trading
Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P. Net Worth
The estimated net worth of Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P. is at least $157 Million dollars as of 2024-06-24. Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P. is the 2201 Interest of corporation controlled by you of Gaush Meditech Ltd and owns about 11,375,840 shares of Gaush Meditech Ltd (HKSE:02407) stock worth over $157 Million. Details can be seen in Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P. has not made any transactions after 2022-12-12 and currently still holds the listed stock(s).
Transaction Summary of Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P.
Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P. owns 1 companies in total, including Gaush Meditech Ltd (HKSE:02407) .
Insider Ownership Summary of Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HKSE:02407 | Gaush Meditech Ltd | 2022-12-12 | 2201 Interest of corporation controlled by you |
Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P. Latest Holdings Summary
Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P. currently owns a total of 1 stock. Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P. owns 11,375,840 shares of Gaush Meditech Ltd (HKSE:02407) as of December 12, 2022, with a value of $157 Million.
Latest Holdings of Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HKSE:02407 | Gaush Meditech Ltd | 2022-12-12 | 11,375,840 | 13.80 | 156,986,592 |
Holding Weightings of Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P.
Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P. Form 4 Trading Tracker
According to the SEC Form 4 filings, Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P. has made a total of 1 transactions in Gaush Meditech Ltd (HKSE:02407) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Gaush Meditech Ltd is the sale of 11,375,840 shares on December 12, 2022, which brought Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P. around $0.
Insider Trading History of Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P.
- 1
Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P. Trading Performance
Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P. Ownership Network
Ownership Network List of Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P.
Ownership Network Relation of Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P.
![Insider Network Chart](https://static.gurufocus.com/insider-network.png)
Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P. Owned Company Details
What does Gaush Meditech Ltd do?
Who are the key executives at Gaush Meditech Ltd?
Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P. is the 2201 Interest of corporation controlled by you of Gaush Meditech Ltd. Other key executives at Gaush Meditech Ltd include 2102 Investment manager OrbiMed Advisors III Limited , 2102 Investment manager OrbiMed Asia GP III, L.P. , and 2102 Investment manager OrbiMed Asia Partners III, L.P. .
Gaush Meditech Ltd (HKSE:02407) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Gaush Meditech Ltd (HKSE:02407) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Gaush Meditech Ltd (HKSE:02407) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Gaush Meditech Ltd (HKSE:02407)'s detailed insider trading history can be found in Insider Trading Tracker table.
Gaush Meditech Ltd Insider Transactions
Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P. Mailing Address
Above is the net worth, insider trading, and ownership report for Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P.. Currently GuruFocus does not have mailing address information for Warburg Pincus (Cayman) China-Southeast Asia II GP, L.P..